Matthew Davidson

Matthew Davidson

Direttore/Membro del Consiglio presso ADIAL PHARMACEUTICALS, INC.

Patrimonio netto: 770 350 $ in data 30/06/2026

42 anni
Health Technology
Consumer Services

Profilo

Matthew Davidson was the founder of Verrica Pharmaceuticals, Inc., founded in 2013, where the title held was Chief Scientific Officer & Director.
Dr. Davidson is the founder of Azora Therapeutics, Inc., founded in 2019, holding the titles of President, Chief Executive & Financial Officer.
Dr. Davidson currently holds the position of Director & Chief Development Officer at Adial Pharmaceuticals, Inc., starting in 2026.
Dr. Davidson completed undergraduate education at the University of California, Berkeley, and earned a doctorate from Stanford University School of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
12/06/2026 300.918 ( 13,75% ) 770 350 $ 30/06/2026

Posizioni attive di Matthew Davidson

SocietàPosizioneInizio
ADIAL PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 11/06/2026
Amministratore Delegato 01/03/2019

Precedenti posizioni note di Matthew Davidson

Formazione di Matthew Davidson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

14

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private5

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Matthew Davidson